126 related articles for article (PubMed ID: 18670236)
1. HIV immune reconstitution syndrome in sub-Saharan Africa.
Murdoch DM; Venter WD; Feldman C; Van Rie A
AIDS; 2008 Aug; 22(13):1689-90. PubMed ID: 18670236
[No Abstract] [Full Text] [Related]
2. HIV immune reconstitution syndrome in sub-Saharan Africa.
Easterbrook PJ
AIDS; 2008 Mar; 22(5):643-5. PubMed ID: 18317006
[No Abstract] [Full Text] [Related]
3. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review.
Barth RE; van der Loeff MF; Schuurman R; Hoepelman AI; Wensing AM
Lancet Infect Dis; 2010 Mar; 10(3):155-66. PubMed ID: 20185094
[TBL] [Abstract][Full Text] [Related]
4. Delivery of antiretroviral therapy in sub-saharan Africa.
Weller I
Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
[No Abstract] [Full Text] [Related]
5. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
6. The Meaning of "Rapid" Antiretroviral Therapy Initiation for Adolescents With Human Immunodeficiency Virus in Sub-Saharan Africa.
Zanoni BC; Haberer JE
J Infect Dis; 2020 Aug; 222(5):705-707. PubMed ID: 31682259
[No Abstract] [Full Text] [Related]
7. ChatGPT has the potential to enhance antiretroviral therapy adherence among adolescents with HIV in sub-Saharan Africa.
Kizito S
Med Educ Online; 2023 Dec; 28(1):2246781. PubMed ID: 37563880
[No Abstract] [Full Text] [Related]
8. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis associated immune reconstitution inflammatory syndrome.
Sinha S; Sharma SK
Indian J Tuberc; 2010 Oct; 57(4):177-9. PubMed ID: 21141335
[No Abstract] [Full Text] [Related]
10. Traditional health practitioners are key to scaling up comprehensive care for HIV/AIDS in sub-Saharan Africa.
Homsy J; King R; Balaba D; Kabatesi D
AIDS; 2004 Aug; 18(12):1723-5. PubMed ID: 15280784
[No Abstract] [Full Text] [Related]
11. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
Staehelin C; Rickenbach M; Low N; Egger M; Ledergerber B; Hirschel B; D'Acremont V; Battegay M; Wagels T; Bernasconi E; Kopp C; Furrer H;
AIDS; 2003 Oct; 17(15):2237-44. PubMed ID: 14523281
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study.
Janssen S; Osbak K; Holman R; Hermans S; Moekotte A; Knap M; Rossatanga E; Massinga-Loembe M; Alabi A; Adegnika A; Meenken C; van Vugt M; Kremsner PG; Meintjes G; van der Poll T; Grobusch MP
Infection; 2017 Oct; 45(5):669-676. PubMed ID: 28349491
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.
Murdoch DM; Venter WD; Feldman C; Van Rie A
AIDS; 2008 Mar; 22(5):601-10. PubMed ID: 18317001
[TBL] [Abstract][Full Text] [Related]
14. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
van Zyl GU; Frenkel LM; Chung MH; Preiser W; Mellors JW; Nachega JB
AIDS; 2014 Nov; 28(18):2643-8. PubMed ID: 25493592
[No Abstract] [Full Text] [Related]
15. Risk factors for immune reconstitution inflammatory syndrome under combination antiretroviral therapy can be aetiology-specific.
Espinosa E; Ormsby CE; Vega-Barrientos RS; Ruiz-Cruz M; Moreno-Coutiño G; Peña-Jiménez A; Peralta-Prado AB; Cantoral-Díaz M; Romero-Rodríguez DP; Reyes-Terán G
Int J STD AIDS; 2010 Aug; 21(8):573-9. PubMed ID: 20975091
[TBL] [Abstract][Full Text] [Related]
16. HIV/AIDS in 2004: the epidemiologist's point of view.
Girardi E; Lauria FN; Ippolito G
Cell Death Differ; 2005 Aug; 12 Suppl 1():837-44. PubMed ID: 15776000
[No Abstract] [Full Text] [Related]
17. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
[No Abstract] [Full Text] [Related]
18. Alcohol and antiretroviral adherence? What about Africa?
Van geertruyden JP; Woelk G; Mukumbi H; Ryder R; Colebunders R
J Acquir Immune Defic Syndr; 2010 Aug; 54(4):e10. PubMed ID: 20611030
[No Abstract] [Full Text] [Related]
19. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
[TBL] [Abstract][Full Text] [Related]
20. Achieving HIV targets by 2030: the possibility of using debt relief funds for sustainable HIV treatment in sub-Saharan Africa.
Abah RC
J Public Health Policy; 2020 Dec; 41(4):421-435. PubMed ID: 32747703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
